Does ELIQUIS Cause Dyspnoea? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Dyspnoea have been filed in association with ELIQUIS. This represents 2.9% of all adverse event reports for ELIQUIS.
41
Reports of Dyspnoea with ELIQUIS
2.9%
of all ELIQUIS reports
2
Deaths
10
Hospitalizations
How Dangerous Is Dyspnoea From ELIQUIS?
Of the 41 reports, 2 (4.9%) resulted in death, 10 (24.4%) required hospitalization, and 2 (4.9%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELIQUIS. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does ELIQUIS Cause?
Haemorrhage (79)
Gastrointestinal haemorrhage (72)
Dizziness (65)
Rash (51)
Epistaxis (49)
Headache (49)
Adverse event (40)
Diarrhoea (37)
Contusion (34)
Drug dose omission (34)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ELIQUIS Alternatives Have Lower Dyspnoea Risk?
ELIQUIS vs ELOSULFASE ALFA
ELIQUIS vs ELOTUZUMAB
ELIQUIS vs ELOXATIN
ELIQUIS vs ELRANATAMAB
ELIQUIS vs ELRANATAMAB-BCMM